In fact, so-called sclerosis refers to treatment of cystal malformations by injection of a sclerogen into the cavity cavity, which closes an abnormally extended vein and causes tumour atrophy.
As spongy vascular tumours are venomic malformations, with little or no visible effect on either oral or epitomizing drugs, combined with the high trauma and risk of surgical treatment and the inadequacy of other non-surgery treatments, such as laser therapy, copper needle retention and the treatment of injury to limb oppression, compared to sclerosis treatment, Sclerosis treatment has become the dominant method for the treatment of vascular malformations, including spongy vascular tumours, as well as a consensus among national and international scholars after years of clinical experience.
When sclerosis is used to treat spongy vascular tumours, the clinician first takes the necessary pain relief measures, then injects into the tumours aqueous ethanol, Bolecin, fish liver oilic acid or polyocalol sclerants, and then rehabilitates the appearance and function by destroying the vascular internal skin cell and reducing the vascular fibrosis and size of the scaffold.
If the patient’s spongiform aneurysm is deep or if a significant tissue organ has been attacked, it needs to be precisely located under the guidance of ultrasound or CT, MRI (i.e. intervention (embolism) treatment, as is commonly known).
In general, spongiform vascular tumors in most patients can be treated more satisfactorily after one to three stylized treatments, while widespread and dispersed spongiform vascular tumours require more than one treatment and are less effective.
Angioplasm.
